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Volume 54, Number 6 Abstracts 1863Methods:To determine the extent to which ovine ADSCs differentiate
into an aSMC phenotype, we compared cell morphology and growth
characteristics, expression of SMC-specific proteins, and the ability of cells to
contract type-I collagen gels. ADSC lines were established from the vascular
stromal fraction of subcutaneous fat biopsies from three individual sheep and
maintained in stem cell media or grown in SMC differentiation media (DM)
(-MEM, 1% embryonic FBS, penn/strep and L-glut)  TGF-	 (10ng/
mL). Cells were also exposed to uniaxial stretch during differentiation to
determine any additional effects on phenotype (collagen-coated Flexcell
plates, 10% strain, 60 Hz).
Results: Each ADSC isolate was first shown to be multi-potent by
growing subcultures in osteogenic or adipogenic differentiation media and
documenting typical mineralization and lipid accumulation, respectively.
ADSCmaintained in stem cell media were smaller than control aSMC, grew
to confluence one to two days faster, and expressed low levels of the SMC
markers -actin, myosin heavy chain (sm-MHC) and smoothelin. In con-
trast, after 7 days in DM, ADSC had developed morphology and growth
kinetics similar to control aSMC and showed significant up-regulation of all
protein markers. TGF- or cyclical stretch did not further enhance marker
expression compared to DM alone. Unlike control aSMC, undifferentiated
ADSC did not contract 3-dimensional collagen gels (diam. after 18 hrs: 14.6
 0.2 vs 18.0  0.0 mm, P  .001). Remarkably, ADSC grown in DM for
7 days contracted collagen gels as vigorously as control aSMCs, while the
addition of TGF-â limited contraction slightly (13.0  0.2 vs 16.8  0.2
mm, respectively, P  .002 vs both ADSC and aSMC).
Conclusions: Multi-potent ADSCs are readily obtained from subcu-
taneous fat, grow rapidly, but express low levels of SMC-specific markers at
baseline. Switching to a low-serumDM significantly shifts ADSC phenotype
toward that of control aSMC but, in contrast to previous reports, no
additional shift was seen with growth factors or mechanical stretch. These
observations support the potential for SMC-like cells differentiated from
ADSC to provide a less invasive source of autologous SMC for clinical
application of blood vessel bioengineering. Further research is needed to
determine the capacity of these cells to populate vascular scaffolds and the
fate of cells after implantation.
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Introduction:Despite advancements in renal replacement therapy, the
mortality rate for acute kidney injury (AKI) remains unchanged over the past
several decades, likely due to extra-renal organ dysfunction. Kidney isch-
emia-reperfusion injury (IRI) activates cellular and soluble mediators that
stimulate the innate and adaptive immune systems and incite a distinct
remote organ pulmonary pro-inflammatory and pro-apoptotic response.
Ischemic AKI induces tumor necrosis factor 1 (TNFR1)-dependent lung
apoptosis and results in lungmicrovascular barrier dysfunction in vivo. Here,
we focused on kidney-lung crosstalk at the cellular level and hypothesized
that endothelial cells (ECs), with their critical role in maintaining the
semipermeable barrier, are important targets leading to disruption of micro-
vascular permeability during ischemic AKI. In a series of parallel in vivo and
in vitro experiments, we sought to characterize the pulmonary EC-specific
transcriptional and structural response to kidney IRI and hypothesized that
TNF-/TNFR1 signaling inhibition would attenuate EC alterations during
ischemic AKI.
Methods: Male C57/BL6 mice or Sprague-Dawley rats underwent
60 minutes of bilateral kidney ischemia (IRI) or sham laparotomy (sham)
and were sacrificed at 24 hours. In mice, co-localization studies with
DAPI, TUNEL, and CD34 staining were performed, and lung microvas-
cular ECs [CD45/CD31] were isolated with novel tissue digestion
techniques followed by antibody-coupled magnetic bead sorting to 95%
purity (by flow cytometry). Isolated ECs were analyzed with Apoptosis
and EC Activation RT-PCR “SuperArrays” each containing 84 pathway-
specific genes. In parallel, rat lung microvascular ECs (RLMVECs)
grown to confluence were treated for 24 hours with serum from rats
during IRI or sham, and assays included 1) DAPI/phalloidin staining to
assess the actin cytoskeleton, 2) poly(ADP-ribose) polymerase(PARP)
activity assay to measure apoptosis, and 3) RT-PCR to quantify transcrip-
tion of TNF super-family and pro-inflammatory genes / pre-treat-
ment with Etanercept.Results: Immunofluorescence micrographs stained with DAPI,
UNEL and CD34 co-localized, suggesting lung EC apoptosis in vivo
uring ischemic AKI. Isolated lung ECs exhibited significant changes
uring ischemic AKI in prominent genes identified by “SuperArray”
nalysis, including genes related to apoptosis (Dapk1, RhoB, Bcl10,
asL, Cflar), the TNF super-family (TNF-, Tnfrsf10b[DR5],
rp53inp1, Trp63) and inflammation (E-Selectin, ICAM-1, IL-6). In
itro, RLMVECs treated with IRI serum displayed actin stress fiber
ormation and increased apoptosis at 4 and 24 hours compared to sham
0.24 0.06 vs 1.71 0.44*; 0.24 0.07 vs 1.33 0.36*). RLMVECs
lso demonstrated increased transcription of TNF super-family related
enes during IRI, and the pro-inflammatory transcriptional response was
ttenuated by TNF-/TNFR1 signaling inhibition with Etanercept. *P
.05 vs sham, n  4/group.
Conclusions: Kidney-lung crosstalk during ischemic AKI is a complex
athophysiological process involving the activation of several key cellular
nd soluble factors that drive remote organ injury. Ischemic AKI produces
hanges in the pulmonary EC phenotype with the induction of actin
ytoskeleton rearrangement, apoptosis, and a distinct pro-inflammatory and
ro-apoptotic transcriptional response. Additionally, kidney IRI drives in-
reased transcription of TNF super-family genes, and TNF-/TNFR1
ignaling inhibition attenuates the EC inflammatory response in vitro.
uture endeavors to characterize the EC-specific response and effector
echanisms to remote organ injury during ischemic AKI may reveal poten-
ial therapeutic targets for kidney-lung crosstalk.
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Background: Lower extremity Computed Tomography Angiography
CTA) is frequently utilized for anatomic assessment of peripheral arterial
isease. In patients requiring lower extremity bypass, duplex ultrasound
DUS) is routinely obtained to evaluated great saphenous vein (GSV) for use
s conduit. GSV is visible on CTA images but not routinely assessed or
ncluded in study interpretation. We hypothesized that CTA images could
e used tomeasure GSV diameters, and that these diameters would correlate
ith DUS measurements.
Methods: Consecutive patients evaluated preoperatively with both
TA and DUS vein mapping prior to lower extremity bypass were identified
t a single hospital. All CTAs were performed using standard protocol
ithout venous phase imaging. Minimum above- and below-knee GSV
iameters were independently measured from electronically archived CTA
mages by two observers. Adequate GSV was defined as minimum DUS
iameter 3 mm. Reproducibility of CTA-based diameter measurements
etween observers was evaluated using intraclass correlation coefficients.
orrelation between CTA and DUS-based GSV diameters was evaluated
ith linear regression and Spearman correlation coefficients. Cut-points for
dentification of adequate GSV bypass conduit using CTA were determined
sing receiver operating characteristic curves.
Results: Thirty six limbs were evaluated in 27 patients. In the absence
f previous surgical removal, GSV was visible on all CTAs reviewed. No
nstances of GSV thrombosis were identified on DUS. Mean minimum
bove-knee GSV diameters were 3.8  1.3 mm for CTA versus 2.9  0.9
m forDUS;mean below-kneeGSV diameters were 2.6 0.8mm for CTA
ersus 2.5  0.9 mm for DUS. Inter-observer reproducibility of CTA
iameter measurements was excellent above-knee [intraclass correlation
oefficient (95% CI): 0.86 (0.75-0.92)] and below-knee [intraclass correla-
ion coefficient (95% CI): 0.77 (0.57-0.88)]. Correlation between CTA and
US-based GSV diameters was highly significant at both above-knee (
 
64, P  .0001) and below-knee (
  .60, P  .0017) locations (Fig). For
dentification of adequate bypass conduit using CTA, above-knee GSV
iameter 3.9 mm was 65% sensitive and 74% specific; below- knee GSV
iameter 3.0mm was 56% sensitive and 94% specific.
Conclusions: CTA-based GSV diameter measurements have excellent
eproducibility and highly significant correlation with DUS. CTA-based
SV diameter is a specific but relatively insensitive indicator of adequate
ypass conduit. When CTA-based diameters indicate inadequate GSV by-
ass conduit, confirmatory DUS vein mapping is warranted. Confirmatory
US vein mapping may be unnecessary when adequate vein diameter is
dentified on CTA.
